Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

Paytm's Subsidiary First Game Technologies Faces ₹5712 Crore GST Tax Demand, Plans Legal Challenge

Paytm's Subsidiary First Game Technologies Faces ₹5712 Crore GST Tax Demand, Plans Legal Challenge

Indian Traders Hopeful For Good Business On Akshaya Tritiya: CAIT

Indian Traders Hopeful For Good Business On Akshaya Tritiya: CAIT

International Monetary Fund To Review Pakistan's USD 1.3 Billion Package On May 9

International Monetary Fund To Review Pakistan's USD 1.3 Billion Package On May 9

Gold Climbs ₹1,050 To ₹99,450/10 Gm, Silver Bounces ₹3,500 Ahead Of Akshaya Tritiya

Gold Climbs ₹1,050 To ₹99,450/10 Gm, Silver Bounces ₹3,500 Ahead Of Akshaya Tritiya

India-US Meeting In Washington Makes Headway On Bilateral Trade Agreement

India-US Meeting In Washington Makes Headway On Bilateral Trade Agreement